Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer

Catarina Rendeiro, Andrew Sheriff, Tushar K. Bhattacharya, Joseph V. Gogola, Jeffrey H. Baxter, Hong Chen, William G Helferich, Edward J Roy, Justin S Rhodes

Research output: Contribution to journalArticle

Abstract

The negative impact of chemotherapy on cognitive function in cancer patients has gained increasing attention in the last decade. Whilst the short-term acute effects on cognition are expected following chemotherapy, the persistence of such impairments in the long-term is still in question. This is despite clinical evidence indicating cognitive difficulties may persist well beyond treatment and affect quality of life. In the present study, we assessed the long-term (3 months) cognitive impact of chemotherapy in a mouse model intended to mimic the human female post-menopausal population receiving chemotherapy for breast cancer. Ovariectomized, female, C57BL/6J mice received two doses of Doxorubicin, Cyclophosphamide, and 5-Fluorouracil or saline vehicle (control), separated by one week. During this interval, mice received BrdU injections to label dividing cells. Results indicate a persistent impairment in learning and recall (1 h, 24 h and 48 h) on the Morris water maze, reduced survival and differentiation of new neurons (BrdU+/NeuN+), and a persistent decline in proliferation of new cells (Ki67+) in the dentate gyrus. Locomotor activity, motor performance, and anxiety-like behavior were unaffected. We further evaluated the efficacy of a diet enriched in omega-3-fatty acids (DHA + EPA + DPA), in reversing long-term chemotherapy deficits but no rescue was observed. The model described produces long-term cognitive and cellular impairments from chemotherapy that mimic those observed in humans. It could be useful for identifying mechanisms of action and to test further the ability of lifestyle interventions (e.g., diet) for ameliorating chemotherapy-induced cognitive impairments.

Original languageEnglish (US)
Pages (from-to)10-22
Number of pages13
JournalBehavioural Brain Research
Volume315
DOIs
StatePublished - Dec 15 2016

Fingerprint

Neurogenesis
Breast Neoplasms
Drug Therapy
Bromodeoxyuridine
Cognition
Performance Anxiety
Diet
Aptitude
Dentate Gyrus
Omega-3 Fatty Acids
Locomotion
Spatial Learning
Spatial Memory
Inbred C57BL Mouse
Fluorouracil
Doxorubicin
Cyclophosphamide
Life Style
Quality of Life
Cell Proliferation

Keywords

  • Chemotherapy
  • Fish-oil
  • Learning
  • Memory
  • Neurogenesis
  • PUFAs

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer. / Rendeiro, Catarina; Sheriff, Andrew; Bhattacharya, Tushar K.; Gogola, Joseph V.; Baxter, Jeffrey H.; Chen, Hong; Helferich, William G; Roy, Edward J; Rhodes, Justin S.

In: Behavioural Brain Research, Vol. 315, 15.12.2016, p. 10-22.

Research output: Contribution to journalArticle

@article{4e6461de0da64077806c76c5fefea2a6,
title = "Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer",
abstract = "The negative impact of chemotherapy on cognitive function in cancer patients has gained increasing attention in the last decade. Whilst the short-term acute effects on cognition are expected following chemotherapy, the persistence of such impairments in the long-term is still in question. This is despite clinical evidence indicating cognitive difficulties may persist well beyond treatment and affect quality of life. In the present study, we assessed the long-term (3 months) cognitive impact of chemotherapy in a mouse model intended to mimic the human female post-menopausal population receiving chemotherapy for breast cancer. Ovariectomized, female, C57BL/6J mice received two doses of Doxorubicin, Cyclophosphamide, and 5-Fluorouracil or saline vehicle (control), separated by one week. During this interval, mice received BrdU injections to label dividing cells. Results indicate a persistent impairment in learning and recall (1 h, 24 h and 48 h) on the Morris water maze, reduced survival and differentiation of new neurons (BrdU+/NeuN+), and a persistent decline in proliferation of new cells (Ki67+) in the dentate gyrus. Locomotor activity, motor performance, and anxiety-like behavior were unaffected. We further evaluated the efficacy of a diet enriched in omega-3-fatty acids (DHA + EPA + DPA), in reversing long-term chemotherapy deficits but no rescue was observed. The model described produces long-term cognitive and cellular impairments from chemotherapy that mimic those observed in humans. It could be useful for identifying mechanisms of action and to test further the ability of lifestyle interventions (e.g., diet) for ameliorating chemotherapy-induced cognitive impairments.",
keywords = "Chemotherapy, Fish-oil, Learning, Memory, Neurogenesis, PUFAs",
author = "Catarina Rendeiro and Andrew Sheriff and Bhattacharya, {Tushar K.} and Gogola, {Joseph V.} and Baxter, {Jeffrey H.} and Hong Chen and Helferich, {William G} and Roy, {Edward J} and Rhodes, {Justin S}",
year = "2016",
month = "12",
day = "15",
doi = "10.1016/j.bbr.2016.07.043",
language = "English (US)",
volume = "315",
pages = "10--22",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer

AU - Rendeiro, Catarina

AU - Sheriff, Andrew

AU - Bhattacharya, Tushar K.

AU - Gogola, Joseph V.

AU - Baxter, Jeffrey H.

AU - Chen, Hong

AU - Helferich, William G

AU - Roy, Edward J

AU - Rhodes, Justin S

PY - 2016/12/15

Y1 - 2016/12/15

N2 - The negative impact of chemotherapy on cognitive function in cancer patients has gained increasing attention in the last decade. Whilst the short-term acute effects on cognition are expected following chemotherapy, the persistence of such impairments in the long-term is still in question. This is despite clinical evidence indicating cognitive difficulties may persist well beyond treatment and affect quality of life. In the present study, we assessed the long-term (3 months) cognitive impact of chemotherapy in a mouse model intended to mimic the human female post-menopausal population receiving chemotherapy for breast cancer. Ovariectomized, female, C57BL/6J mice received two doses of Doxorubicin, Cyclophosphamide, and 5-Fluorouracil or saline vehicle (control), separated by one week. During this interval, mice received BrdU injections to label dividing cells. Results indicate a persistent impairment in learning and recall (1 h, 24 h and 48 h) on the Morris water maze, reduced survival and differentiation of new neurons (BrdU+/NeuN+), and a persistent decline in proliferation of new cells (Ki67+) in the dentate gyrus. Locomotor activity, motor performance, and anxiety-like behavior were unaffected. We further evaluated the efficacy of a diet enriched in omega-3-fatty acids (DHA + EPA + DPA), in reversing long-term chemotherapy deficits but no rescue was observed. The model described produces long-term cognitive and cellular impairments from chemotherapy that mimic those observed in humans. It could be useful for identifying mechanisms of action and to test further the ability of lifestyle interventions (e.g., diet) for ameliorating chemotherapy-induced cognitive impairments.

AB - The negative impact of chemotherapy on cognitive function in cancer patients has gained increasing attention in the last decade. Whilst the short-term acute effects on cognition are expected following chemotherapy, the persistence of such impairments in the long-term is still in question. This is despite clinical evidence indicating cognitive difficulties may persist well beyond treatment and affect quality of life. In the present study, we assessed the long-term (3 months) cognitive impact of chemotherapy in a mouse model intended to mimic the human female post-menopausal population receiving chemotherapy for breast cancer. Ovariectomized, female, C57BL/6J mice received two doses of Doxorubicin, Cyclophosphamide, and 5-Fluorouracil or saline vehicle (control), separated by one week. During this interval, mice received BrdU injections to label dividing cells. Results indicate a persistent impairment in learning and recall (1 h, 24 h and 48 h) on the Morris water maze, reduced survival and differentiation of new neurons (BrdU+/NeuN+), and a persistent decline in proliferation of new cells (Ki67+) in the dentate gyrus. Locomotor activity, motor performance, and anxiety-like behavior were unaffected. We further evaluated the efficacy of a diet enriched in omega-3-fatty acids (DHA + EPA + DPA), in reversing long-term chemotherapy deficits but no rescue was observed. The model described produces long-term cognitive and cellular impairments from chemotherapy that mimic those observed in humans. It could be useful for identifying mechanisms of action and to test further the ability of lifestyle interventions (e.g., diet) for ameliorating chemotherapy-induced cognitive impairments.

KW - Chemotherapy

KW - Fish-oil

KW - Learning

KW - Memory

KW - Neurogenesis

KW - PUFAs

UR - http://www.scopus.com/inward/record.url?scp=84981306137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981306137&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2016.07.043

DO - 10.1016/j.bbr.2016.07.043

M3 - Article

C2 - 27478140

AN - SCOPUS:84981306137

VL - 315

SP - 10

EP - 22

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -